Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Cognition enhancer found devoid of neurotoxicity in vitro

Aug. 26, 1997

Actiq scheduled for FDA advisory committee review

Aug. 26, 1997

Cephalon awarded patents for IGF-1

Aug. 26, 1997

FDA approves Watson's estazolam

Aug. 25, 1997

Amgen acquires rights to FKBP-neuroimmunophilin ligands

Aug. 25, 1997

New nonpeptide substance P antagonist from Pfizer

Aug. 25, 1997

New D4 antagonist may aid in the search for antipsychotic drugs

Aug. 25, 1997

Titan's Spheramine receives orphan drug designation

Aug. 25, 1997

FDA approves hand implant for quadriplegics

Aug. 22, 1997

Substance P antagonists discovered at Kotobuki

Aug. 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Asia
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...